Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation
about
Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrated genomic approaches ...... boring oncogenic EGFR mutation
@en
Integrated genomic approaches ...... oring oncogenic EGFR mutation.
@nl
type
label
Integrated genomic approaches ...... boring oncogenic EGFR mutation
@en
Integrated genomic approaches ...... oring oncogenic EGFR mutation.
@nl
prefLabel
Integrated genomic approaches ...... boring oncogenic EGFR mutation
@en
Integrated genomic approaches ...... oring oncogenic EGFR mutation.
@nl
P2093
P2860
P356
P1433
P1476
Integrated genomic approaches ...... boring oncogenic EGFR mutation
@en
P2093
Angela Kyung-Joo Park
Hideo Watanabe
Hongwei Holly Yin
Jaehyung Koo
Je-Gun Joung
Jeonghee Cho
Joon Oh Park
Joon Seol Bae
Joshua M Francis
P2860
P304
13797-13809
P356
10.18632/ONCOTARGET.7318
P407
P577
2016-02-11T00:00:00Z